NECS Medicines Optimisation

Skip to content
  • Home
  • News
    • Prescribing News
    • Recent Newsletter Posts
    • Recent Newsletters
  • Formularies & Guidelines
    • Cumbria
      • Lothian Joint Formulary
    • Durham and Darlington
      • County Durham and Darlington Formulary
      • Durham & Darlington APC
      • Shared Care Guidelines & Transfer of Prescribing Policies
      • Durham & Darlington Community Pharmacy
    • North of Tyne and Gateshead
      • North of Tyne and Gateshead Formulary
      • Gateshead Legacy Guidelines
    • South Tyneside
      • South Tyneside Formulary
    • Tees
      • Tees Formulary
    • Yorkshire & Humber
      • Calderdale
      • East Riding of Yorkshire
      • Hull
      • North Lincolnshire
      • North East Lincolnshire
  • Controlled Drugs
    • CD newsletter
    • Contact Details
    • Destructions and reporting incidents
    • Guidance documents
  • Resources
    • 2018/19 Flu Campaign
      • National Support Materials
      • C&NE Flu Campaign Knowledge Hub
    • Antibiotics
      • PHE Primary care guidance: diagnosing and managing infections
      • NICE Antimicrobial Prescribing Guidelines & Evidence Summaries
    • Cardiovascular
    • Care Homes
      • NECS good practice guidance and tools for care homes
      • CareHomeNews Archive
    • Central Nervous System
    • Diabetes
    • Local Decision Making
    • Patient Group Directions
    • Prescribing Systems & Processes
      • Supply Issues_Shortages
    • Respiratory
    • Self Care
    • Useful Links
  • Education & Training
    • Antibiotics eLearning
    • Inhaler Technique eLearning
    • Oral Nutrition Support eLearning
    • Electronic Repeat Dispensing eLearning
    • Events
    • Other medicines training resources
    • Posters and publications

NICE guidance briefings

The following document is designed to give an executive summary of the key points in relation to medicines optimisation arising from NICE guidance.  It highlights some issues CCGs may wish to consider in terms of implementation of the guidance.

  • NICE TA325 Nalmefene for reducing alcohol consumption in people with alcohol dependence – summary for commissioners

Post navigation

← Increase to NHS prescription charges from 1st April 2016 Why Asthma Still Kills – National Review of Asthma Deaths (NRAD) →

Prescribing Committees

  • Cumbria
  • Durham & Darlington
  • North of Tyne & Gateshead
  • Tees

Contact

  • Contact Us
  • Pharmaceutical Company Representatives
  • Accessibility
  • Cookie & Privacy Policy
  • Terms of Use
  • Contact Us
© NHS Commissioning Board (North of England Commissioning Support)
This site uses cookies to help improve your browsing experience. Read our cookie policy.